Health IT Under a Biden Administration: Part of the Problem or Part of the Solution?
With a flurry of dropped regulations at the end of 2020 and now in the early days of the new Biden Administration, you may be expecting a wholesale change in a new Administration’s approach to health information technology (health IT). I’m not.
Now, it goes without saying that policy, in general, is going to change dramatically under a Biden Administration. Democrats and Republicans have VERY different philosophies and core principles. However, one thing I’ve observed over the years is that both Democrats and Republicans tend to agree that health IT is part of the solution, not part of the problem.
Healthcare Providers: Prepare Now for New Information Blocking Prohibition | Holland & Knight LLP jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Feb 19, 2021 8:05am
In March 2020, the Trump administration released widely anticipated rules that prohibit information sharing and will change how providers, insurers and patients exchange health data. (everythingpossible/GettyImages)
New data-sharing regulations will soon go into effect that lay the groundwork for patients to have easier access to their health information.
When will patients start to see the benefits of these new mandates?
New federal health IT leader Micky Tripathi, Ph.D., believes it s already happening. A lot more is happening behind the scenes that benefit patients that they don’t appreciate. Think about information flowing through networks today: a lot of that does benefit patients, Tripathi, the new national coordinator for health IT, said Thursday during a virtual fireside chat as part of Health Datapalooza.
World Regenerative Medicine Market Outlook to 2030, by Product, Material and Application
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Regenerative Medicine Market size is estimated to be USD 13.22 billion in 2019 and is predicted to reach USD 172.17 billion by 2030 with a CAGR of 26.2% from 2020-2030. Regenerative Medicine are used to regenerate, repair, replace or restore tissues and organs damaged by diseases or due to natural ageing. These medicines help in the restoration of normal cell functions and are widely used to treat various degenerative disorders such as cardiovascular disorders, orthopedic disorders and others. Stem cell plays an important role in regenerative medicine as they are capable of proliferating and differentiating into all cell types in an organism, including extra-embryonic tissues.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.